Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment - A Pragmatic Hybrid Effectiveness/Implementation Trial

NCT06323824 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06323824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06323824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment - A Pragmatic Hybrid Effectiveness/Implementation Trial
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Recruiting
Start date
June 4, 2024
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder